参考文献/References:
[1]Lomivorotov VV,Efremov SM,Kirov MY,et al.Low-Cardiac-Output Syndrome After Cardiac Surgery[J].J Cardiothorac Vasc Anesth,2017,31(1):291-308.[2]Nielsen DV,Hansen MK,Johnsen SP,et al.Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis[J].Anesthesiology,2014,120(5):1098-1108.[3]Erb J,Beutlhauser T,Feldheiser A,et al.Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery[J].J Int Med Res,2014,42(3):750-764.[4]Farmakis D,Alvarez J,Gal TB,et al.Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper[J].Int J Cardiol,2016,222:303-312.[5]高鹏,寇广亚,武延海.左西孟旦治疗老年顽固性充血性心力衰竭并肾功能不全的疗效评价[J].实用医学杂志,2016,32(12):2041-2045.[6]李永梅,梅霞,郑向清,等.左西孟旦治疗失代偿心衰合并肾功能不全患者的疗效观察[J].第三军医大学学报,2016,38(8):897-900.[7]Toller W,Heringlake M,Guarracino F,et al.Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion[J].Int J Cardiol,2015,184:323-336.[8]Badalzadeh R,Yavari R,Chalabiani D.Mitochondrial ATP-sensitive K+ channels mediate the antioxidative influence of diosgenin on myocardial reperfusion injury in rat hearts[J].Gen Physiol Biophys,2015,34(3):323-329.[9]Santillo E,Migale M,Massini C,et al.Levosimendan for Perioperative Cardioprotection: Myth or Reality?[J].Curr Cardiol Rev,2018,14(3):142-152.[10]Anastasiadis K,Antonitsis P,Vranis K,et al.Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study[J].Interact Cardiovasc Thorac Surg,2016,23(5):740-747.[11]van Diepen S,Mehta RH,Leimberger JD,et al.Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery[J].J Thorac Cardiovasc Surg,2020,159(6):2302-2309.e6.[12]Guerrero-Orriach JL,Ariza-Villanueva D,Florez-Vela A,et al.Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase[J].Ther Clin Risk Manag,2016,12:623-630.[13]张芸楠,贾明,潘昱,等.心脏手术术后发生急性肾损伤的相关因素[J].中华医学杂志,2020,100(12):928-932.[14]Desai PM,Sarkar MS,Umbarkar SR.Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study[J].Ann Card Anaesth,2018,21(2):123-128.[15]王保申,史坚,张静波,等.预防性应用左西孟旦对左心室功能障碍患者非体外循环冠状动脉旁路移植术后早期心肌功能的影响[J].实用心脑肺血管病杂志,2022,30(1):90-95.[16]生伟,池一凡,牛兆倬,等.OPCABG术前预防性应用左西孟旦治疗低LVEF冠心病63例[J].中华胸心血管外科杂志,2019,35(2):91-93.[17]Hummel J,Rücker G,Stiller B.Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease[J].Cochrane Database Syst Rev,2017,3(3):CD011312.[18]Cholley B,Caruba T,Grosjean S,et al.Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial[J].JAMA,2017,318(6):548-556.[19]Elbadawi A,Elgendy IY,Saad M,et al.Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery[J].Ann Thorac Surg,2018,105(5):1403-1410.[20]蒙茂龙,王志伟,周楚芝,等.左西孟旦在重症瓣膜病术中缺血预处理中的应用分析[J].临床外科杂志,2019,27(4):352-354.[21]Grieshaber P,Lipp S,Arnold A,et al.Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis[J].J Cardiothorac Surg,2016,11(1):162.[22]杨文聪,彭晓鹏,沈国刚,等.外科换瓣术中心脏停搏前灌注左西孟旦心肌缺血预处理的疗效分析[J].中国医刊,2018,53(10):1127-1130.[23]Mehta RH,Leimberger JD,van Diepen S,et al.Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery[J].N Engl J Med,2017,376(21):2032-2042.[24]Thorlacius EM,Vistnes M,Ojala T,et al.Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data[J].Pediatr Crit Care Med,2021,22(7):e402-e409.[25]樊国亮,陈铁男,刘志刚,等.左西孟旦在重症冠状动脉旁路移植患者术后的作用研究[J].中华老年医学杂志,2019,38(5):516-519.[26]Baysal A,Yanartas M,Dogukan M,et al.Levosimendan improves renal outcome in cardiac surgery: a randomized trial[J].J Cardiothorac Vasc Anesth,2014,28(3):586-594.[27]胡晓燕,徐秋萍.左西孟旦在心脏外科术后重症患者的应用研究[J].中国临床药理学与治疗学,2020,25(9):1027-1032.[28]Landoni G,Lomivorotov VV,Alvaro G,et al.Levosimendan for Hemodynamic Support after Cardiac Surgery[J].N Engl J Med,2017,376(21):2021-2031.[29]Verma S,Rathwell S,Fremes S,et al.Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial[J].Am Heart J,2022,248:35-41.[30]Pan KC,Shankar S,Millar J,et al.Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery[J].Eur J Cardiothorac Surg,2021,59(1):262-268.[31]Wang A,Cui C,Fan Y,et al.Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial[J].Crit Care,2019,23(1):428.[32]Frommeyer G,Kohnke A,Ellermann C,et al.Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model[J].Int J Cardiol,2017,236:423-426.
相似文献/References:
[1]王 琼,徐建华,罗海英,等.葡萄籽提取物对乳房的保健作用及作用机理研究[J].医学信息,2020,33(23):41.[doi:10.3969/j.issn.1006-1959.2020.23.013]
WANG Qiong,XU Jian-hua,LUO Hai-ying,et al.Study on the Health Effect and Mechanism of Grape Seed Extract on Breast[J].Journal of Medical Information,2020,33(11):41.[doi:10.3969/j.issn.1006-1959.2020.23.013]
[2]胡雨平,叶民珠.左西孟旦对经皮冠状动脉介入术后患者心脏储备功能及无复流心力衰竭风险的影响[J].医学信息,2022,35(23):125.[doi:10.3969/j.issn.1006-1959.2022.23.025]
HU Yu-ping,YE Min-zhu.Effect of Levosimendan on Cardiac Reserve Function and Risk of No-reflow Heart Failure in Patients After Percutaneous Coronary Intervention[J].Journal of Medical Information,2022,35(11):125.[doi:10.3969/j.issn.1006-1959.2022.23.025]
[3]巫 菲,薛奋龙,陈洪磊,等.左西孟旦与米力农在心脏瓣膜置换术围术期的心肌保护作用[J].医学信息,2021,34(16):128.[doi:10.3969/j.issn.1006-1959.2021.16.035]
WU Fei,XUE Fen-long,CHEN Hong-lei,et al.Myocardial Protection of Levosimendan and Milrinone During the Perioperative Period of Heart Valve Replacement[J].Journal of Medical Information,2021,34(11):128.[doi:10.3969/j.issn.1006-1959.2021.16.035]
[4]谢自勤,罗 赟,康信勇,等.左西孟旦治疗心力衰竭的临床疗效及对患者心功能及炎性反应的影响[J].医学信息,2024,37(22):110.[doi:10.3969/j.issn.1006-1959.2024.22.027]
XIE Ziqin,LUO Yun,KANG Xinyong,et al.Clinical Efficacy of Levosimendan in the Treatment of Heart Failure and its Effect on Cardiac Function and Inflammatory Response in Patients with Heart Failure[J].Journal of Medical Information,2024,37(11):110.[doi:10.3969/j.issn.1006-1959.2024.22.027]